Ethyl 15-fluoro-14-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.03,8.017,21]henicosa-2(11),3,5,7,9,13(21),14,16,19-nonaene-19-carboxylate | 1026243-38-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶嗪类
• 英文名称: Ethyl 15-fluoro-14-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.03,8.017,21]henicosa-2(11),3,5,7,9,13(21),14,16,19-nonaene-19-carboxylate
• CAS: 1026243-38-8
• 化学式: C₃₁H₃₀FN₃O₆
• 分子量: 559.594
• InChiKey: SGTHLLJQOIBDQE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.4
• 重原子数：
  41
• 可旋转键数：
  6
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  88.6
• 氢给体数：
  0
• 氢受体数：
  9

反应信息

• 作为反应物：
  描述：

  Ethyl 15-fluoro-14-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.03,8.017,21]henicosa-2(11),3,5,7,9,13(21),14,16,19-nonaene-19-carboxylate 在 氢氧化钾 作用下， 以 乙醇 为溶剂， 反应 0.5h， 生成
  参考文献：
  名称：

  Design of New Topoisomerase II Inhibitors Based upon a Quinobenzoxazine Self-Assembly Model

  摘要：

  A new class of pyridobenzophenoxazine compounds has been developed as topoisomerase II inhibitors for anticancer chemotherapy. These compounds were designed based on a proposed model of a quinobenzoxazine self-assembly complex on DNA. They showed excellent inhibitory effects on several tumor cell lines with nanomolar IC50 values. Their cytotoxic potency correlates with their ability to unwind DNA and inhibit topoisomerase II.

  DOI：

  10.1021/jm980265c
• 作为产物：
  描述：

  1-氨基-2-萘酚盐酸盐 在 吡啶 、 sodium hydride 作用下， 以 四氢呋喃 、 二氯甲烷 为溶剂， 反应 60.75h， 生成 Ethyl 15-fluoro-14-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]-18-oxo-12-oxa-1-azapentacyclo[11.7.1.02,11.03,8.017,21]henicosa-2(11),3,5,7,9,13(21),14,16,19-nonaene-19-carboxylate
  参考文献：
  名称：

  Design of New Topoisomerase II Inhibitors Based upon a Quinobenzoxazine Self-Assembly Model

  摘要：

  A new class of pyridobenzophenoxazine compounds has been developed as topoisomerase II inhibitors for anticancer chemotherapy. These compounds were designed based on a proposed model of a quinobenzoxazine self-assembly complex on DNA. They showed excellent inhibitory effects on several tumor cell lines with nanomolar IC50 values. Their cytotoxic potency correlates with their ability to unwind DNA and inhibit topoisomerase II.

  DOI：

  10.1021/jm980265c

文献信息

• Design of New Topoisomerase II Inhibitors Based upon a Quinobenzoxazine Self-Assembly Model
  作者：Qingping Zeng、Yan Kwok、Sean M. Kerwin、Gina Mangold、Laurence H. Hurley

  DOI：10.1021/jm980265c

  日期：1998.10.1

  A new class of pyridobenzophenoxazine compounds has been developed as topoisomerase II inhibitors for anticancer chemotherapy. These compounds were designed based on a proposed model of a quinobenzoxazine self-assembly complex on DNA. They showed excellent inhibitory effects on several tumor cell lines with nanomolar IC50 values. Their cytotoxic potency correlates with their ability to unwind DNA and inhibit topoisomerase II.